表紙
市場調査レポート

ミオクローヌス:世界の治験レビュー

Myoclonus Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 308784
出版日 ページ情報 英文 71 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
ミオクローヌス:世界の治験レビュー Myoclonus Global Clinical Trials Review, H2, 2014
出版日: 2014年07月21日 ページ情報: 英文 71 Pages
概要

当レポートでは、ミオクローヌスに関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

イントロダクション

  • ミオクローヌス
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対するミオクローヌスの治験件数比率

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系の治験件数に対するミオクローヌスの治験件数比率

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

ミオクローヌス治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Taro Pharmaceutical Industries Ltd.
  • 代表的な研究機関・病院の治験の概要
    • National Pediatric Myoclonus Center
    • Nanjing Medical University
    • First Affiliated Hospital of Henan College
    • Foundation IRCCS Neurological Institute Carlo Besta
    • Hospital Sant Joan de Deu Barcelona
    • National Institute of Neurological Disorders and Stroke
    • Assistance Publique - Hopitaux de Paris
    • Academic Medical Center
    • Mashhad University of Medical Sciences
    • Institut Curie

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2252CTIDB

GlobalData's clinical trial report, "Myoclonus Global Clinical Trials Review, H2, 2014" provides data on the Myoclonus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Myoclonus
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Myoclonus to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Myoclonus to Central Nervous System Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Myoclonus
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Myoclonus Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Taro Pharmaceutical Industries Ltd.
      • Clinical Trial Overview of Taro Pharmaceutical Industries Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • National Pediatric Myoclonus Center
      • Clinical Trial Overview of National Pediatric Myoclonus Center
      • Nanjing Medical University
      • Clinical Trial Overview of Nanjing Medical University
      • First Affiliated Hospital of Henan College
      • Clinical Trial Overview of First Affiliated Hospital of Henan College
      • Foundation IRCCS Neurological Institute Carlo Besta
      • Clinical Trial Overview of Foundation IRCCS Neurological Institute Carlo Besta
      • Hospital Sant Joan de Deu Barcelona
      • Clinical Trial Overview of Hospital Sant Joan de Deu Barcelona
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Mashhad University of Medical Sciences
      • Clinical Trial Overview of Mashhad University of Medical Sciences
      • Institut Curie
      • Clinical Trial Overview of Institut Curie
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Myoclonus Therapeutics, Global, Clinical Trials by Region, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myoclonus Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Myoclonus Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Myoclonus Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Myoclonus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Myoclonus to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Myoclonus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myoclonus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myoclonus to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Myoclonus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Myoclonus Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myoclonus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Taro Pharmaceutical Industries Ltd., 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by National Pediatric Myoclonus Center, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by First Affiliated Hospital of Henan College, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Foundation IRCCS Neurological Institute Carlo Besta, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Sant Joan de Deu Barcelona, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Curie, 2014*

List of Figures

  • Myoclonus Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myoclonus Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Myoclonus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Myoclonus Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Myoclonus to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Myoclonus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myoclonus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myoclonus to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Myoclonus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myoclonus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top